Mesoblast Ownership | Who Owns Mesoblast?
Mesoblast Ownership Summary
Mesoblast is owned by 1.55% institutional investors, 0.07% insiders, and 98.37% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0.06% of MESO shares. iShares Biotechnology ETF is the top mutual fund, with 0.49% of its assets in Mesoblast shares.
MESO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Mesoblast | 1.55% | 0.07% | 98.37% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 727.25K | 0.06% | $14.40M |
Summit x | 145.66K | 0.01% | $2.88M |
Prosperity wealth management | 93.25K | 0.01% | $1.85M |
Penbrook management | 91.08K | 0.01% | $1.80M |
Lazari capital management | 45.47K | 0.00% | $900.25K |
Pine valley investments ltd liability | 20.93K | 0.00% | $414.43K |
Chapin davis | 15.00K | 0.00% | $122.55K |
Vanguard personalized indexing management | 12.80K | 0.00% | $253.46K |
Ballentine partners | 11.20K | 0.00% | $221.82K |
Sageworth trust | 10.00K | 0.00% | $198.00K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Penbrook management | 91.08K | 1.23% | $1.80M |
Prosperity wealth management | 93.25K | 0.76% | $1.85M |
Summit x | 145.66K | 0.64% | $2.88M |
Lazari capital management | 45.47K | 0.36% | $900.25K |
Chapin davis | 15.00K | 0.04% | $122.55K |
Pine valley investments ltd liability | 20.93K | 0.02% | $414.43K |
China universal asset management | 6.78K | 0.01% | $134.16K |
Sageworth trust | 10.00K | 0.01% | $198.00K |
Gamma investing | 6.71K | 0.01% | $132.88K |
Advisors preferred | 1.41K | 0.00% | $29.04K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock funding, inc. /de | 727.25K | 0.00% | 645.77K |
Vanguard personalized indexing management | 12.80K | 0.00% | 12.80K |
Ballentine partners | 11.20K | 0.00% | 11.20K |
Sageworth trust | 10.00K | 0.01% | 10.00K |
Pine valley investments ltd liability | 20.93K | 0.02% | 9.22K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Xy capital | - | - | -29.85K |
Penbrook management | 91.08K | 1.23% | -16.20K |
Perkins coie trust | - | - | -11.50K |
Advisors preferred | 1.41K | 0.00% | -4.99K |
Summit x | 145.66K | 0.64% | -2.04K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Vanguard personalized indexing management | 12.80K | 0.00% | 12.80K | $253.46K |
Ballentine partners | 11.20K | 0.00% | 11.20K | $221.82K |
Sageworth trust | 10.00K | 0.01% | 10.00K | $198.00K |
China universal asset management | 6.78K | 0.01% | 6.78K | $134.16K |
Us bancorp \de\ | 942.00 | - | 942.00 | $18.65K |
Sold Out
Holder | Change |
---|---|
Perkins coie trust | -11.50K |
Xy capital | -29.85K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 45 | - | 1,532,837 | 3.28% | 1 | 68.66% | 21 | -32.26% | 12 | 300.00% |
Jun 30, 2024 | 45 | 40.63% | 1,484,211 | 36.87% | 1 | 124.54% | 31 | 82.35% | 3 | -72.73% |
Mar 31, 2024 | 32 | - | 1,084,385 | -7.60% | 1 | 310.73% | 17 | 30.77% | 11 | 37.50% |
Dec 31, 2023 | 32 | -17.95% | 1,173,622 | -11.54% | - | 96.41% | 13 | -7.14% | 8 | -33.33% |
Sep 30, 2023 | 39 | -17.02% | 1,326,779 | -26.10% | - | 61.77% | 14 | -39.13% | 12 | 71.43% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Biotechnology ETF | 630.36K | 0.49% | 61.72K |
Fidelity Nasdaq Composite Index | 18.25K | 0.01% | 7.22K |
iShares Nasdaq US Biotech ETF USD Acc | 15.47K | 0.01% | - |
ActivePassive International Equity ETF | 8.47K | 0.01% | 42.00 |
Quantified Global Fund Investor | 6.40K | 0.01% | -378.00 |
ProShares Ultra Nasdaq Biotechnology | 1.48K | 0.00% | - |
Invesco Nasdaq Biotechnology ETF | 1.22K | 0.00% | - |
DFA International Core Equity I | 796.00 | 0.00% | - |
Morningstar Global Markets ADR | 6.00 | - | 6.00 |
MESO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools